Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Tapentadol hydrochloride by Hikma Pharmaceuticals USA Inc., resulting in an updated labeling/indication for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

SUPPL AP for TAPENTADOL (TAPENTADOL HYDROCHLORIDE)